“…As a result, they are used in combination therapy with other antidiabetic drugs such as MET (Lajara, 2014). The reported methods for analysis of DAPA and MET in combination include UV spectrophotometry (Bhavyasri & Surekha, 2020; Jani et al, 2015), RP‐HPLC (Abbas et al, 2020; Khalil et al, 2018; Urooj et al, 2017), LC–UV (Hassib et al, 2019), LC–MS/MS (Dias et al, 2019; Shah et al, 2019), capillary electrophoresis (Maher et al, 2019) and TLC–spectrodensitometric methods for simultaneous analysis of DAPA and MET (Abdelrahman et al, 2020; Nasser et al, 2018). These methods are less sensitive with several mobile phases and are applied only to pharmaceutical formulations.…”